Projects per year
Personal profile
Education
- Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1992-1999 M.D., School of Medicine, National Taiwan University
Experience
- 2026.08- Chairperson, Taipei Cancer Center, Taipei Medical University
- 2026.08- Director, Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2024.08- Chairperson, Taipei Cancer Center, Taipei Medical University
- 2024.08-2026.07 Medical Deputy Director, Department of Medical Administration, Taipei Medical University-Shuang Ho
- 2022.02- Associate Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2021.11-2024.07 Vice Director, Department of Surgery, Taipei Medical University Shuang Ho Hospital
- Director, Division of General Surgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
- 2015.11-2022.01 Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2006.07-2011.02 Attending Physician, Far Eastern Memorial Hospital
- 2001.07-2006.06 Resident Physician, National Taiwan University Hospital
Research Interests
- 一般外科
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Hsin-An Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 10 Finished
-
Regulation of M6a Rna Methylation in Pancreatic Ductal Adenocarcinoma and Its Impact on Chemotherapy Resistance
Chen, H.-A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
探討雷公藤內酯在胰臟癌中增強化療藥物的效果及誘導鐵凋亡作用之機制
Chen, H.-A. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討雷公藤內酯在胰臟癌中增強化療藥物的效果及誘導鐵凋亡作用之機制
Chen, H.-A. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
The Potential Application of a Natural Compound, Tripolate, for Enhancing the Therapeutic Efficacy of Sorafenib in Hepatic Cancer
Chen, H.-A. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
探討代謝重整、非編碼核糖核酸與腫瘤抑制因子之相互作用對胰臟癌Gemcitabine抗藥性的影響及其在轉譯醫學上的應用: 鑑定腫瘤分子機制與找尋具潛力之治療標靶 (第二年)-表觀體學對胰腺癌代謝重編程的影響
Chen, H.-A. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells (Experimental & Molecular Medicine, (2024), 56, 9, (2065-2081), 10.1038/s12276-024-01300-4)
Park, J. M., Su, Y. H., Fan, C. S., Chen, H. H., Qiu, Y. K., Chen, L. L., Chen, H. A., Ramasamy, T. S., Chang, J. S., Huang, S. Y., Chang, W. S. W., Lee, A. Y. L., Huang, T. S., Kuo, C. C. & Chiu, C. F., Mar 2025, In: Experimental and Molecular Medicine. 57, 3, p. 700-701 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma
Wang, W. Y., Hsu, T. W., Su, Y. H., Su, C. M., Wang, T. H., Chiu, C. F., Tsai, K. Y., Huang, C. Y., Chen, H. A. & Liao, P. H., 2025, In: International Journal of Medical Sciences. 22, 16, p. 4353-4364 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma
Hsu, T.-W., Wang, W.-Y., Chen, H.-A., Wang, T.-H., Su, C.-M., Liao, P. H., Chen, A., Tsai, K.-Y., Kokotos, G., Kuo, C., Chiu, C.-F. & Su, Y.-H., Feb 10 2025, In: Cancer & Metabolism. 13Research output: Contribution to journal › Article › peer-review
-
Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells
Park, J. M., Su, Y. H., Fan, C. S., Chen, H. H., Qiu, Y. K., Chen, L. L., Chen, H. A., Ramasamy, T. S., Chang, J. S., Huang, S. Y., Chang, W. S. W., Lee, A. Y. L., Huang, T. S., Kuo, C. C. & Chiu, C. F., Sept 2024, In: Experimental and Molecular Medicine. 56, 9, p. 2065-2081 17 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Citations (Scopus) -
Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape
Hsu, T. W., Wang, W. Y., Chen, A., Chiu, C. F., Liao, P. H., Chen, H. A., Su, C. M., Shen, S. C., Tsai, K. Y., Wang, T. H. & Su, Y. H., Dec 2024, In: Journal of Cellular Physiology. 239, 12, e31416.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)